Pharmacological Targeting of the Ephrin Receptor Kinase Signalling by GLPG1790 in Vitro and in Vivo Reverts Oncophenotype, Induces Myogenic Differentiation and Radiosensitizes Embryonal Rhabdomyosarcoma Cells

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-017-0530-z

Related search